Laboratoires Delbert
2 products tracked · names used in filings: Laboratoires Delbert
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 21 May 2026🇪🇺 Application withdrawn (EU)
Orblid (bevacizumab): EU application withdrawn
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Orblid bevacizumab | Application withdrawn | |
| 🇪🇺 | Ceplene histamine dihydrochloride | Authorised | 2008-10-07 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.